PFPeA exposure drives hepatoxicity and liver fibrosis via oxidative stress/Wnt5a-induced hepatocyte senescence

Perfluoropentanoic acid (PFPeA), one of short-chain PFASs, has raised concern due to existence in the environment. The hepatotoxicity of PFPeA remains to be further elucidated. Cellular senescence, a distinct cellular state that occurs under stress conditions, plays a vital role in the progression of various diseases. However, the contribution of cellular senescence to PFPeA induced liver toxicity remains unclear. Our study investigated the specific role of cellular senescence in PFPeA induced liver injury and its underlying mechanisms in C57BL/6 J mice and THLE-2 cells. Our results demonstrated that PFPeA exposure at 5 μg/mL significantly induces hepatocyte senescence and liver injury, and fibrosis in mice. Further experiments revealed that PFPeA triggers excessive ROS production in hepatocytes, which leads to sustained activation of the Wnt5a signaling pathway, subsequently inducing cellular senescence and senescence-associated secretory phenotype (SASP) secretion, and ultimately resulting in liver dysfunction and fibrosis. Combination therapy targeting both senescence and Wnt5a significantly alleviated PFPeA -induced liver injury. In summary, our study provides compelling evidence highlighting the important role of cellular senescence in PFPeA induced liver injury. This research broadens our understanding of PFPeA induced hepatotoxicity and provides potential therapeutic and preventive strategies for managing PFPeA-related liver injury. • This study investigates the health effect of novel PFASs PFPeA in liver, providing evidence in harmful effect of PFPeA chronic exposure with environmental relevant concentrations. • PFPeA exposure induces ROS accumulation in hepatocytes, further activates Wnt5a expression induces cellular senescence, resulting in liver dysfunction and liver fibrosis. • Targeting Wnt5a and senescent cells alleviates PFPeA exposure induce liver damage.